Found 5 matching trials
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
PHASE1The purpose of this platform study is to evaluate the safety, tolerability,...
Location
Ironwood Cancer and Research Centers
Bevacizumab Plus Modiifed FOLFIRINOX in Ovarian, Fallopian Tube, or Primary Peritoneal Mucinous Carcinoma
PHASE2This research study is evaluating a modified FOLFIRINOX plus bevacizumab th...
Location
Yonsei University Health System, Severance Hospital
GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
EARLY_PHASE1There is a growing number of patients diagnosed with gastrointestinal cance...
Location
University of Arizona Cancer Center
Ablative Therapy of Oligometastatic Tumor After Response to Conventional First Line Treatment
N/AAdvancements in systemic antineoplastic therapies have led to improved over...
CPI-613 (Devimistat) in Combination With Modified FOLFIRINOX Plus Bevacizumab in Patients With Metastatic Colorectal Cancer
PHASE1Pre-clinical in vitro and in vivo data as well as early phase 1 clinical tr...
Location
Multiple Locations